Pharmacist-integrated model of medication treatment for opioid use disorder (CTN-0116). 09/01/2021 - 03/01/2024. N01DA-19-2250. Task order 75N95021F00006 (TO25).
Ended Awarded Last action
- Contract number
- 75N95021F00006
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $686,833
Award facts
- Opportunity
-
- 75N95021F00006 Solicitation number
- Contract value 100% obligated
- $686,833.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this award
The Emmes Company LLC was awarded a cost-plus-fixed-fee delivery order valued at approximately $687,000 by the National Institutes of Health's National Institute on Drug Abuse to support the Clinical Trials Network's Pharmacist-Integrated Model of Medication Treatment for Opioid Use Disorder clinical trial. The two-year contract will utilize the NIH's DATA, STATISTICS, AND CLINICAL TRIAL SUPPORT CENTER indefinite-delivery/indefinite-quantity vehicle to provide data, statistics, and clinical trial support services from September 2021 through March 2024. Specifically, Emmes will assist NIDA's Clinical Trials Network in conducting a study to evaluate the effectiveness of integrating pharmacists into medication treatment programs for opioid use disorder. Performance will take place in Potomac, Maryland. No subcontractors or set aside designations were identified.
Quick answers
Who was awarded contract 75N95021F00006?
75N95021F00006 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on September 1, 2021.
How much is contract 75N95021F00006 worth?
The government has obligated $686,833 on 75N95021F00006.
Is contract 75N95021F00006 an order under another contract?
Yes. 75N95021F00006 is a delivery order under 75N95019D00013, an indefinite delivery contract.
Was contract 75N95021F00006 competed?
The extent of competition for 75N95021F00006 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award